Part of the Medicine and Health Sciences Commons

Works by Daniel C. Brennan in Medicine and Health Sciences

2012

The impact of Medicare's lifetime immunosuppression coverage on racial disparities in kidney graft survival., Timothy F. Page, Robert Woodward, Daniel C. Brennan
Health Management & Policy

2011

The long-term outcomes and costs of diabetes mellitus among renal transplant recipients: Tacrolimus versus cyclosporine., Robert Woodward, Marc C. Flore, Gerardo Machnicki, Daniel C. Brennan
Health Management & Policy

2008

Income-Related Disparities in Kidney Transplant Graft Failures Are Eliminated by Medicare's Immunosuppression Coverage., Robert Woodward, Timothy F. Page, R Soares, Mark A. Schnitzler, K L. Lentine, Daniel C. Brennan
Health Management & Policy

2006

The incidence and costs of sepsis and pneumonia before and after renal transplantation in the United States., Andrea Kutinova, Robert Woodward, Daniel C. Brennan
Health Management & Policy

2005

Renal graft survival and calcineurin inhibitor., Robert Woodward, Andrea Kutinova, Mark A. Schnitzler, Daniel C. Brennan
Health Management & Policy

2004

Cost-effectiveness of extending medicare coverage of immunosuppressive medications to the life of a kidney transplant., Eugene F. Yen, Karen Hardinger, Daniel C. Brennan, Robert Woodward, Niraj M. Desai, Jeffrey S. Crippin, Brian F. Gage, Mark A. Schnitzler
Health Management & Policy

2003

Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients., Robert Woodward, Mark A. Schnitzler, Jack D. Baty, Jeffrey A. Lowell, Lissa Lopez-Rocafort, Seema Haider, Thasia G. Woodworth, Daniel C. Brennan
Health Management & Policy

2001

The Economic Impact of Preservation Time in Cadaveric Liver Transplantation., Mark A. Schnitzler, Robert Woodward, Daniel C. Brennan, James F. Whiting, Raymond J. Tesi, Jeffrey A. Lowell
Health Management & Policy

Effect of Extended Coverage of Immunosuppressive Medications by Medicare on the Survival of Cadaveric Renal Transplants., Robert Woodward, Mark A. Schnitzler, Jeffrey A. Lowell, Edward Spitznagel, Daniel C. Brennan
Health Management & Policy

2000

Economic cost of expanded criteria donors in cadaveric renal transplantation: Analysis of medicare payments., James F. Whiting, Robert Woodward, Edward Y. Zavala, David S. Cohen, Jill E. Martin, Gary G. Singer, Jeffrey A. Lowell, Roy M. First, Daniel C. Brennan, Mark A. Schnitzler
Health Management & Policy

The economic benefit of allocation of kidneys based on cross-reactive group matching., Christopher S. Hollenbeak, Robert Woodward, David S. Cohen, Jeffrey A. Lowell, Gary G. Singer, Raymond J. Tesi, Todd K. Howard, T Mohanakumar, Daniel C. Brennan, Mark A. Schnitzler
Health Management & Policy

A 3-Year Follow-Up of Pre-Emptive vs Deferred Treatment of Cytomegalovirus Disease in Renal Transplantation., Mark A. Schnitzler, Troy G. Metheney, Jose F. Rueda, Robert Woodward, Jeffrey A. Lowell, Gary G. Singer, Surendra Shenoy, Todd K. Howard, Gregory A. Storch, Daniel C. Brennan
Health Management & Policy

Economics of the antithymocyte globulins Thymoglobulin® and Atgam® in the treatment of acute renal transplant rejection, Mark A. Schnitzler, Robert Woodward, Jeffrey A. Lowell, Leah Amir, Timothy Schroeder, Gary G. Singer, Daniel C. Brennan
Health Management & Policy

Cadaveric versus living donor kidney transplantation: A medicare payment analysis., Marc D. Smith, Robert Woodward, David S. Cohen, Gary G. Singer, Daniel C. Brennan, Jeffrey A. Lowell, Todd K. Howard, Mark A. Schnitzler
Health Management & Policy

1999

The economic implications of HLA matching in cadaveric renal transplantation., Mark A. Schnitzler, Christopher S. Hollenbeak, David S. Cohen, Robert Woodward, Jeffrey A. Lowell, Gary G. Singer, Raymond J. Tesi, Todd K. Howard, T Mohanakumar, Daniel C. Brennan
Health Management & Policy

PDF

A randomized, double-blinded comparison of thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients., Daniel C. Brennan, Karen Flavin, Jeffrey A. Lowell, Todd K. Howard, Surendra Shenoy, Sandra Burgess, Sara Dolan, Jennifer M. Kano, Mitchell Mahon, Mark A. Schnitzler, Robert Woodward, William Irish, Gary G. Singer
Health Management & Policy

1998

A new product pricing model using intracorporate market perceptions to extract the value of additional information., Robert Woodward, Leah Amir, Mark A. Schnitzler, Daniel C. Brennan
Health Management & Policy

1997

Cytomegalovirus and HLA-A, B, and DR locus interactions: Impact on renal transplant graft survival., Mark A. Schnitzler, Robert Woodward, Daniel C. Brennan, Donn L. Phelan, Edward Spitznagel, Stuart B. Boxerman, William L. Phelan, Wm. Claiborne Dunagan, Thomas C. Bailey
Health Management & Policy

Impact of cytomegalovirus serology on graft survival in living related kidney transplantation: Implications for donor selection., Mark A. Schnitzler, Robert Woodward, Daniel C. Brennan, Edward Spitznagel, Wm. Claiborne Dunagan, Thomas C. Bailey
Health Management & Policy

The effects of cytomegalovirus serology on graft and recipient survival in cadaveric renal transplantation: Implications for organ allocation., Mark A. Schnitzler, Robert Woodward, Daniel C. Brennan, Edward Spitznagel, Wm. Claiborne Dunagan, Thomas C. Bailey
Health Management & Policy

A pharmacoeconomic comparison of antithymocyte globulin and muromonab CD3 induction therapy in renal transplant recipients., Daniel C. Brennan, Mark A. Schnitzler, Jack D. Baty, Connie S. Ceriotti, Jeffrey A. Lowell, Surendra Shenoy, Todd K. Howard, Robert Woodward
Health Management & Policy